News - Biotechnology, Transgene

Filter

Current filters:

BiotechnologyTransgene

Popular Filters

Sanofi and Transgene launch construction phase of joint bioproduction platform

Sanofi and Transgene launch construction phase of joint bioproduction platform

29-01-2014

French drug major Sanofi and biotech firm Transgene have launched the construction phase of the manufacturing…

BiotechnologyFranceOncologyProductionSanofiTransgene

Korea’s SillaJen to acquire Jennerex in up to $150 million deal

Korea’s SillaJen to acquire Jennerex in up to $150 million deal

27-11-2013

Privately-held South Korean firm SillaJen says it has executed a definitive merger agreement to acquire…

BiotechnologyJennerexMergers & AcquisitionsOncologyPexa-VecSillaJenTransgene

Transgene's Pexa-Vec fails in mid-stage liver cancer study

04-09-2013

French biotech firm Transgene (Euronext Paris: TNG) has revealed that TRAVERSE, a randomized Phase IIb…

BiotechnologyOncologyPexa-VecResearchTransgene

Transgene out-licenses skin cancer candidate TG1042 to Ascend Pharma

04-07-2013

French biotech firm Transgene SA (Euronext Paris: TNG) has granted Ascend Biopharmaceuticals, an emerging…

Ascend PharmaASN-002BiotechnologyLicensingOncologyTG1042Transgene

Sanofi and Transgene collaborate on immunotherapy treatments; NAS designation of Aubagio disputed

25-03-2013

Drug major Sanofi (Euronext: SAN) and fellow France-based biotech firm Transgene SA (NYSE-Euronext: TNG)…

AubagioBiotechnologyEuropeGenzymeImmunologicalsNeurologicalPharmaceuticalProductionRegulationSanofiTransgene

Transgene to seek partner for HCV vaccine TG4040 on strong Ph II results

09-11-2011

French biotech firm Transgene (Euronext Paris: FR0005175080) has revealed interim data showing a substantial…

BiotechnologyLicensingOncologyPharmaceuticalResearchTransgeneVaccines

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top